Apyx Medical (APYX) Stock Statistics & Valuation Metrics

Apyx Medical has a market cap or net worth of $82.45M. The enterprise value is $101.62M.

Apyx Medical has 37,819,477 shares outstanding. The number of shares has decreased by -2.65% in one year.

Apyx Medical’s return on equity (ROE) is -1.65 and return on invested capital (ROIC) is -34.97%.

The current PE Ratio of Apyx Medical is ―. Apyx Medical’s PEG ratio is ―.

In the last 12 months, Apyx Medical had revenue of 48.10M and earned -23.46M in profits. Earnings per share was -0.66.

In the last 12 months, operating cash flow was -4.57M and capital expenditures -915.00K, giving a free cash flow of -5.48M billion.

Apyx Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Apyx Medical upcoming earnings date is Nov 6, 2025, After Close (Confirmed).

Apyx Medical as a current ratio of 5.26, with Debt / Equity ratio of 45.56%

In the past 12 months, Apyx Medical has paid 252.00K in taxes.

Apyx Medical EV to EBITDA ratio is -3.76, with an EV/FCF ratio of -3.37.

Apyx Medical has $31.01M in cash and marketable securities with $38.92M in debt, giving a net cash position of $7.91M billion.

Gross margin is 51.59%, with operating margin of -39.18%, and net profit margin of -48.78%.

The average price target for Apyx Medical is $3.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy